AAO 2024: Gildeuretinol and Stargardt disease: The TEASE program
October 20th 2024Christine Kay, MD sat down to discuss her presentation on gildeuretinol and its slowing of progression of Stargardt disease, studied in the TEASE program at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
AAO 2024: Teleretinal screening for diabetic eye disease
October 20th 2024Christina Y Weng, MD, MBA sat down to discuss the Retina Ophthalmic Technology Assessment Symposium and her journal on teleretinal screening for diabetic eye disease at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
AAO 2024: Defocus curve performance of trifocal IOLs and near activity vision questionnaire outcomes
October 20th 2024Adam Muzychuck, MD, FRCSC, sat down to discuss his presentation on the defocus curve performance of trifocal IOLs and the outcomes of the near activity vision questionnaire given to patients implanted with the Envy full range of vision IOL at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
AAO 2024: Therapies offering hope for patients diagnosed with TED
Published: October 20th 2024 | Updated: October 20th 2024Fatemeh Rajaii, MD, PhD, an associate professor at Wilmer Eye Institute, Johns Hopkins, discusses emerging therapies in thyroid eye disease (TED) from her presentation at the American Academy of Ophthalmology’s annual meeting in Chicago.
AAO 2024: Risk of posterior capsular rupture in second eye of patients with history of PCR
October 19th 2024Abdelrahman Elhusseiny, MD, MSc, sat down with David Hutton of Ophthalmology Times to discuss his presentation on the risk of posterior capsular rupture in fellow eyes of cataract surgery at this year's American Academy of Ophthalmology meeting being held in Chicago, Illinois.
AAO 2024: Clinical updates on Neurotech's NT-501
October 18th 2024Thomas Aaberg Jr, MD sat down to discuss previous presentations by Neurotech at EURETINA and Retina Society as well as upcoming presentations on NT-501 at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
Retina Society 2024: A comparison of tyrosine kinase inhibitors in development
September 26th 2024Sumit Sharma, MD, sat down with Sydney Crago of Modern Retina to discuss his presentation on the 3 tyrosine kinase inhibitors currently in development for the treatment of retina conditions at the Retina Society meeting being held this year in Lisbon, Portugal.
Perfluorohexyloctane ophthalmic solution in the treatment of dry eye
August 22nd 2024At the World Ophthalmology Congress in Vancouver, Canada, John D. Sheppard, MD, MMSc, FACS, presented data on perfluorohexyloctane ophthalmic solution in the treatment of dry eye. He sat down with Ophthalmology Times to discuss the topic in further detail.
Tolerability of cosmetic products on the ocular surface
August 21st 2024At the World Ophthalmology Congress in Vancouver, Canada, Mahnia Madan, OD, FAAO, presented a paper on the tolerability of cosmetic products on the ocular surface. She sat down with Ophthalmology Times to discuss the topic in further detail.